查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1798957

全球医疗微晶片市场

Microchips in Medicine
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 285 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球医疗微晶片市场规模将达到 27 亿美元

全球医疗保健微晶片市场规模预计在2024年为15亿美元，到2030年将达到27亿美元，2024年至2030年的复合年增长率为10.8%。药物输送应用是本报告分析的细分市场之一，预计其复合年增长率将达到12.2%，到分析期结束时市场规模将达到18亿美元。家庭监控应用细分市场在分析期间内的复合年增长率预计为8.1%。

美国市场规模估计为 4.013 亿美元，中国市场预计复合年增长率为 14.9%

预计到2024年，美国医疗微晶片市场规模将达到4.013亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到5.691亿美元，在2024-2030年的分析期间内，复合年增长率为14.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为7.7%和9.6%。在欧洲，预计德国市场的复合年增长率约为8.6%。

全球医疗微晶片市场－主要趋势与驱动因素摘要

微晶片将如何改变未来的医疗诊断和治疗方法？

医疗晶片（也称为植入式或可摄取式医疗晶片）正在重新定义医疗专业人员诊断、监测和治疗各种健康状况的方式。这些基于半导体的设备通常只有米粒大小或更小，用于监测生命征象、将药物输送到目标位置，或确保患者遵医嘱服药。嵌入药丸中的可摄取式感测器晶片可在服药后传输数据，提供药物摄入的即时回馈；而植入式晶片则透过长期生物讯号追踪来监测心血管疾病、癫痫和糖尿病等慢性疾病。

这些晶片融合了生物相容性材料、电子机械系统 (MEMS)、低功耗半导体和无线资料传输技术。与需要医生上门或使用笨重设备的传统监测技术不同，微晶片能够提供持续、被动和远端的健康监测。随着全球医疗保健向个人化医疗转型，这些晶片使医生能够根据即时收集的患者特定数据量身定制治疗方法。

哪些技术突破将推动微晶片在医疗保健领域的应用？

材料科学、奈米製造和微流体的关键创新正在推动微晶片在医疗保健领域的部署。如今，晶片配备了生物感测器，可以检测pH值、血糖浓度、电解质和酶活性等生化讯号。电源效率显着提升，晶片仅需使用小型电池或能源采集机制（例如压电和热电系统）即可运作数月甚至数年。超低功耗积体电路 (IC) 和无线晶片系统(SoC) 实现了向智慧型手机和云端平台的无缝资料传输。

最有前景的领域之一是智慧药物传输系统，该系统中的晶片经过预先编程，可在生物触发或远端控制下释放药物。该系统已在癌症治疗和荷尔蒙治疗的临床前试验中得到检验。嵌入心律调节器和神经刺激设备的微晶片可以连续传输心律和神经活动数据。最近的趋势还包括皮下植入晶片和电子纹身，它们可以非侵入性地追踪水分、体温和电生理讯号。

此外，随着基于区块链的安全资料传输和人工智慧主导的分析技术的发展，晶片产生的数据正逐渐实用化预测性诊断和人口健康管理。 FDA 等监管机构正在认可此类晶片的安全性和效用，从而加速其临床应用。

哪个医疗领域采用微晶片技术的比例最高？

慢性病管理是最重要的应用领域之一。例如，糖尿病患者受益于配备微晶片的连续血糖监测仪 (CGM)，该监测仪能够不间断地将资料传输到胰岛素帮浦和医疗保健提供者。在心臟科领域，心律调节器和去心房颤动中的植入式晶片可用于追踪心律不整、心率变异性和心臟衰竭的早期征兆。神经系统应用包括即时监测癫痫发作、颅内压和脊髓活动的晶片。

在製药领域，可摄取微晶片正被纳入临床实验和依从性监测。 Proteus Digital Health 是该领域的先驱，推出了一款可指示服药成功的药丸，用于验证思觉失调症。在整形外科和关节置换领域，晶片被嵌入植入中，用于监测癒合率、负荷动态和感染指标。

兽医学是另一个平行成长的领域，其中RFID微晶片用于牲畜和宠物的追踪、诊断和疫苗监测。从地理位置来看，北美在研发、临床试验和商业化方面处于领先地位，其次是欧洲，欧洲对病患资料法规和公共卫生整合有着浓厚的兴趣。由于政府在数位健康基础设施和半导体创新方面的努力，亚太地区——特别是中国、日本和韩国——正在迅速崛起。

是什么推动了全球医疗微晶片市场的成长？

全球医疗保健微晶片市场的成长受到多种因素的推动，包括慢性病负担的加重、医疗保健服务向以患者为中心的转变，以及远端监控技术的日益普及。即时和连续诊断的需求促使医疗保健系统将微晶片纳入主流治疗途径。感测器和晶片的微型化和低价格降低了进入门槛，使其能够在住院和门诊环境中广泛部署。

智慧型手机、穿戴式装置和物联网平台在医疗保健领域的应用日益增长，正在为晶片诊断技术建立数位生态系统。新冠疫情加速了远距远端医疗的普及，并凸显了非接触式监测的需求。製药公司越来越多地将晶片嵌入口服药物中，以提高患者用药依从性，尤其是在精神健康和感染疾病领域。

医疗保健产业向基于结果的报销和预防性护理的转变，进一步支持了微晶片提供的持续监测工具。在美国、英国和欧洲部分地区，数位治疗和远距离诊断的报销代码正在不断扩展，从而提升了其商业性可行性。随着安全架构和惰性材料的应用，资料隐私和生物相容性的担忧得到解决，微晶片医疗保健的未来将继续在机构、技术和市场方面获得发展动力。

部分

用途（药物传输用途、家庭监测用途、其他用途）、最终用途（医院最终用途、研究最终用途、其他最终用途）

受访公司范例

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • BioTelemetry（a Philips company）
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies（A Qualcomm Life Company）
  • Cepheid（a Danaher company）
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom（now part of Baxter）
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer（now part of Revvity）
  • Siemens Healthineers
  • Zimmer Biomet

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP39059

Global Microchips in Medicine Market to Reach US$2.7 Billion by 2030

The global market for Microchips in Medicine estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Drug Delivery Application, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Home Monitoring Application segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$401.3 Million While China is Forecast to Grow at 14.9% CAGR

The Microchips in Medicine market in the U.S. is estimated at US$401.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$569.1 Million by the year 2030 trailing a CAGR of 14.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.7% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.

Global Microchips in Medicine Market - Key Trends & Drivers Summarized

How Are Microchips Transforming the Future of Medical Diagnostics and Therapeutics?

Microchips in medicine-also known as implantable or ingestible medical chips-are redefining how healthcare professionals diagnose, monitor, and treat a wide array of health conditions. These semiconductor-based devices, often the size of a grain of rice or smaller, are being used to monitor vital signs, deliver drugs at targeted locations, or verify patient adherence to prescribed regimens. Ingestible sensor chips embedded in pills can transmit data once ingested, providing real-time feedback on medication intake. Meanwhile, implantable chips monitor chronic diseases such as cardiovascular disorders, epilepsy, or diabetes through long-term biosignal tracking.

These chips represent a fusion of biocompatible materials, micro-electromechanical systems (MEMS), low-power semiconductors, and wireless data transmission. Unlike traditional monitoring techniques that require hospital visits or bulky equipment, microchips offer continuous, passive, and remote health surveillance. As global healthcare pivots toward personalized medicine, these chips enable physicians to adjust treatment regimens based on patient-specific data collected in real time-minimizing adverse drug reactions and maximizing therapeutic efficacy.

What Technological Breakthroughs Are Driving Adoption of Microchips in Healthcare?

Significant innovations in materials science, nanofabrication, and microfluidics are propelling the deployment of microchips in medical settings. Chips now feature biosensors capable of detecting biochemical signals such as pH, glucose levels, electrolytes, or enzyme activity. Power efficiency has been vastly improved, allowing chips to function for months or even years using miniature batteries or energy harvesting mechanisms (e.g., piezoelectric or thermoelectric systems). Ultra-low-power integrated circuits (ICs) and wireless systems-on-chip (SoCs) enable seamless data transmission to smartphones or cloud platforms.

One of the most promising areas is smart drug delivery systems, wherein chips are pre-programmed to release drugs in response to biological triggers or via remote control. This has been validated in preclinical studies for cancer treatment and hormone therapy. Another area of rapid growth is biosignal telemetry, where microchips embedded in pacemakers or neurostimulators relay continuous data on heart rhythms or neural activity. Recent developments also include skin-interfaced microchips and electronic tattoos capable of non-invasively tracking hydration, temperature, and electrophysiological signals.

Furthermore, blockchain-based secure data transmission and AI-driven analytics are making chip-generated data actionable in predictive diagnostics and population health management. Regulatory bodies such as the FDA are increasingly acknowledging the safety and utility of such chips, thereby accelerating clinical adoption.

Which Medical Fields Are Seeing the Highest Adoption Rates of Microchip Technologies?

Chronic disease management is among the most significant application areas. Diabetic patients, for instance, benefit from continuous glucose monitors (CGMs) equipped with microchips, enabling non-stop data relay to insulin pumps or healthcare providers. In cardiology, implantable chips inside pacemakers or defibrillators are used to track arrhythmias, heart rate variability, and early signs of heart failure. Neurological applications include chips that monitor seizures, intracranial pressure, or spinal cord activity in real time.

The pharmaceutical sector is integrating ingestible microchips into drug trials and compliance monitoring. Proteus Digital Health pioneered this segment, launching a pill that signals successful ingestion-a feature being utilized to verify adherence in schizophrenia and hepatitis C treatments. The oncology field is testing microchips for intra-tumoral drug delivery or thermal ablation guidance. In orthopedic and prosthetic applications, chips are being embedded in implants to monitor healing rates, load dynamics, and infection markers.

Veterinary medicine is another parallel growth segment where RFID microchips are used for tracking, diagnostics, and vaccine monitoring in livestock and pets. Geographically, North America leads in R&D, clinical trials, and commercialization, followed by Europe with a strong focus on patient data regulation and public health integration. Asia-Pacific-particularly China, Japan, and South Korea-is emerging rapidly due to government initiatives in digital health infrastructure and semiconductor innovation.

What Is Fueling Growth in the Global Microchips in Medicine Market?

The growth in the global microchips in medicine market is driven by several factors, including the rising burden of chronic diseases, a shift toward patient-centric healthcare delivery, and increased adoption of remote monitoring technologies. The demand for real-time, continuous diagnostics has prompted healthcare systems to integrate microchips into mainstream treatment pathways. Miniaturization and affordability of sensors and chips are reducing entry barriers, enabling broader deployment across both inpatient and outpatient settings.

A parallel rise in the use of smartphones, wearables, and IoT platforms in healthcare is creating a supportive digital ecosystem for chip-enabled diagnostics. The COVID-19 pandemic accelerated telehealth acceptance and highlighted the need for contactless monitoring-reinforcing the value of ingestible or implantable microchips. Pharmaceutical companies are increasingly embedding chips in oral formulations to improve drug compliance, especially in mental health and infectious disease segments.

The healthcare sector’s movement toward outcome-based reimbursement and preventative care further incentivizes continuous monitoring tools that microchips offer. Reimbursement codes for digital therapeutics and remote diagnostics are expanding across the US, UK, and parts of Europe, bolstering commercial viability. As concerns over data privacy and biocompatibility are addressed through secure architectures and inert materials, the microchip-enabled healthcare future continues to gain institutional, technological, and market momentum.

SCOPE OF STUDY:

The report analyzes the Microchips in Medicine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Delivery Application, Home Monitoring Application, Other Applications); End-Use (Hospitals End-Use, Research Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • BioTelemetry (a Philips company)
  • Biotronik
  • Boston Scientific Corporation
  • Capsule Technologies (A Qualcomm Life Company)
  • Cepheid (a Danaher company)
  • Cochlear Limited
  • Dexcom Inc.
  • GE HealthCare
  • Hillrom (now part of Baxter)
  • Honeywell Life Sciences
  • Implantica
  • Masimo Corporation
  • Medtronic Plc
  • Microchip Biotechnologies Inc.
  • NXP Semiconductors
  • PerkinElmer (now part of Revvity)
  • Siemens Healthineers
  • Zimmer Biomet

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Microchips in Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Development of Smart Pills and Ingestible Microchips Throws the Spotlight on Digital Medicine
    • Rising Need for Continuous Patient Monitoring Drives Adoption of Implantable Microchips
    • Advances in Biocompatible Semiconductor Materials Enhance Medical Integration of Microchips
    • Growth in Remote Patient Management Solutions Spurs Demand for Chip-Enabled Wearable Devices
    • Use of Microchips for Drug Release Timing Enhances Precision Therapy Protocols
    • Surge in Interest in Digital Biomarkers Expands Use of Embedded Chips for Vital Sign Capture
    • Integration of NFC and RFID Technologies Drives Development of Smart Packaging in Pharma
    • Expansion of Electronic Health Monitoring Systems Strengthens Business Case for Chip-Enabled Devices
    • Innovation in Energy Harvesting and Wireless Charging Enhances Microchip Usability in Medicine
    • Growing Investment in Neurotechnology Spurs Development of Brain-Implanted Monitoring Chips
    • Advances in Lab-on-Chip Diagnostics Drive Miniaturized Point-of-Care Testing Applications
    • Regulatory Approvals for Ingestible Sensors Expand Commercialization of Diagnostic Microchips
    • Collaborations with Pharma Firms Accelerate Development of Companion Diagnostics Using Chips
    • Increase in Clinical Trials Using Sensor-Based Monitoring Enhances Microchip Market Penetration
    • Focus on AI Integration Within Chipsets Supports Personalized and Predictive Healthcare
    • Growth in Geriatric Care Needs Propels Use of Monitoring Chips in Long-Term Care Settings
    • Use of Blockchain and Smart Contracts in Chip-Enabled Drug Traceability Strengthens Compliance
    • Expansion of Telehealth Infrastructure Globally Spurs Use of Chip-Based Mobile Health Devices
    • Development of Closed-Loop Drug Delivery Systems Integrates Microchips for Feedback Control
    • Public Acceptance of Biometric Implants Opens Pathways for Wider Use of Microchips in Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microchips in Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Drug Delivery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Home Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microchips in Medicine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microchips in Medicine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION